These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 12269970)

  • 1. Colonic delivery of 4-aminosalicylic acid using amylose-ethylcellulose-coated hydroxypropylmethylcellulose capsules.
    Tuleu C; Basit AW; Waddington WA; Ell PJ; Newton JM
    Aliment Pharmacol Ther; 2002 Oct; 16(10):1771-9. PubMed ID: 12269970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of formulation technology to assess regional gastrointestinal drug absorption in humans.
    Basit AW; Podczeck F; Newton JM; Waddington WA; Ell PJ; Lacey LF
    Eur J Pharm Sci; 2004 Feb; 21(2-3):179-89. PubMed ID: 14757489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colon-specific delivery tablets of sodium 4-aminosalicylic acid.
    Li Y; Li HJ; Yang GR; Gu WP; Ma YK; Zhang MH; Sun J; Sun SJ
    Yao Xue Xue Bao; 2006 Oct; 41(10):927-32. PubMed ID: 17184108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of the in-vivo drug release from pellets film-coated with a dispersion of high amylose starch and ethylcellulose for potential colon delivery.
    Freire C; Podczeck F; Ferreira D; Veiga F; Sousa J; Pena A
    J Pharm Pharmacol; 2010 Jan; 62(1):55-61. PubMed ID: 20722999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploiting gastrointestinal bacteria to target drugs to the colon: an in vitro study using amylose coated tablets.
    Wilson PJ; Basit AW
    Int J Pharm; 2005 Aug; 300(1-2):89-94. PubMed ID: 16023805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of the coating formulation on enzymatic digestibility and drug release from 5-aminosalicylic acid pellets coated with mixtures of high-amylose starch and Surelease intended for colon-specific drug delivery.
    Freire C; Podczeck F; Veiga F; Sousa J
    Drug Dev Ind Pharm; 2010 Feb; 36(2):161-72. PubMed ID: 19678749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enzymatically degraded Eurylon 6 HP-PG: ethylcellulose film coatings for colon targeting in inflammatory bowel disease patients.
    Karrout Y; Neut C; Siepmann F; Wils D; Ravaux P; Deremaux L; Flament MP; Dubreuil L; Lemdani M; Desreumaux P; Siepmann J
    J Pharm Pharmacol; 2010 Dec; 62(12):1676-84. PubMed ID: 21054393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulsatile systems for colon targeting of budesonide: in vitro and in vivo evaluation.
    Yehia SA; Elshafeey AH; Elsayed I
    Drug Deliv; 2011 Nov; 18(8):620-30. PubMed ID: 22111975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The potential of organic-based amylose-ethylcellulose film coatings as oral colon-specific drug delivery systems.
    Siew LF; Basit AW; Newton JM
    AAPS PharmSciTech; 2000 Jul; 1(3):E22. PubMed ID: 14727908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutron activation based gamma scintigraphic evaluation of enteric-coated capsules for local treatment in colon.
    Marvola T; Marvola J; Kanerva H; Ahonen A; Lindevall K; Marvola M
    Int J Pharm; 2008 Feb; 349(1-2):24-9. PubMed ID: 17869037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microbiota-triggered colonic delivery: robustness of the polysaccharide approach in the fed state in man.
    Basit AW; Short MD; McConnell EL
    J Drug Target; 2009 Jan; 17(1):64-71. PubMed ID: 19016069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel polymeric film coatings for colon targeting: Drug release from coated pellets.
    Karrout Y; Neut C; Wils D; Siepmann F; Deremaux L; Flament MP; Dubreuil L; Desreumaux P; Siepmann J
    Eur J Pharm Sci; 2009 Jun; 37(3-4):427-33. PubMed ID: 19491034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amylose formulations for drug delivery to the colon: a comparison of two fermentation models to assess colonic targeting performance in vitro.
    Siew LF; Man SM; Newton JM; Basit AW
    Int J Pharm; 2004 Apr; 273(1-2):129-34. PubMed ID: 15010137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formulation and development of gastroretentive drug delivery system for ofloxacin.
    Ali J; Hasan S; Ali M
    Methods Find Exp Clin Pharmacol; 2006 Sep; 28(7):433-9. PubMed ID: 17003848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of simulated gastrointestinal conditions on drug release from pectin/ethylcellulose as film coating for drug delivery to the colon.
    Ahmed IS
    Drug Dev Ind Pharm; 2005 May; 31(4-5):465-70. PubMed ID: 16093212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and in-vitro evaluation of a colon-specific controlled release drug delivery system.
    Talukder RM; Fassihi R
    J Pharm Pharmacol; 2008 Oct; 60(10):1297-303. PubMed ID: 18812022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of novel spray coated soft elastic gelatin capsule sustained release formulations of nifedipine.
    Abd El-Sattar Fahmy S; Christensen JM; Ayres JW
    Drug Dev Ind Pharm; 2009 Aug; 35(8):1009-21. PubMed ID: 19274589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Injection Molded Capsules for Colon Delivery Combining Time-Controlled and Enzyme-Triggered Approaches.
    Federica C; Alice M; Saliha M; Marco U; Anastasia F; Alessandra M; Lucia Z; Christel N; Florence S; Juergen S; Andrea G
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32168895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Ulcerative colitis--colon delivery of 5-aminosalicylic acid].
    Muraoka M; Kimura G; Zhaopeng H; Takada K
    Nihon Rinsho; 1998 Mar; 56(3):788-94. PubMed ID: 9549374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An in vivo comparison of intestinal pH and bacteria as physiological trigger mechanisms for colonic targeting in man.
    McConnell EL; Short MD; Basit AW
    J Control Release; 2008 Sep; 130(2):154-60. PubMed ID: 18639950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.